Viewing Study NCT00712166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-01-25 @ 12:01 AM
Study NCT ID: NCT00712166
Status: COMPLETED
Last Update Posted: 2010-12-20
First Post: 2008-07-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
None Lung Infection View
None Pseudomonas Aeruginosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cystic fibrosis View
None pseudomonas aeruginosa View
None lung infection View
None CFQ-R View
None inhaled antibiotic View
None aztreonam lysine View